Intravascular Large B Cell Lymphoma of the Breast: A Rare Entity.

B-cell lymphoma Intravascular breast non-Hodgkin

Journal

Breast cancer : basic and clinical research
ISSN: 1178-2234
Titre abrégé: Breast Cancer (Auckl)
Pays: United States
ID NLM: 101474356

Informations de publication

Date de publication:
2021
Historique:
received: 31 05 2021
accepted: 09 09 2021
entrez: 4 11 2021
pubmed: 5 11 2021
medline: 5 11 2021
Statut: epublish

Résumé

Intravascular large B-cell lymphoma (IVLBCL) is a rare and high-grade disease of neoplastic lymphoid cells within the vascular lumina of small- to medium-sized vessels. The disease carries a grim prognosis despite robust treatment protocols. We discuss the case of a 58-year-old female who presented with mammographic screening abnormality which led to more investigations and ultimately to this diagnosis. The patient had no prior history of a lymphoma or in situ and invasive carcinoma of the breast. To our knowledge, IVLBCL of the breast is a very rare and an unusual location for this type of a lymphoma and so far, only five reported cases. Through our case report, we not only discuss the case but also review literature on this rare entity.

Identifiants

pubmed: 34733104
doi: 10.1177/11782234211050728
pii: 10.1177_11782234211050728
pmc: PMC8558590
doi:

Types de publication

Case Reports

Langues

eng

Pagination

11782234211050728

Informations de copyright

© The Author(s) 2021.

Déclaration de conflit d'intérêts

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

World J Surg Oncol. 2012 Jul 16;10:151
pubmed: 22800119
Oncologist. 2006 Sep;11(8):923-8
pubmed: 16951396
J Cutan Pathol. 2020 Jul;47(7):643-648
pubmed: 32087036
J Med Case Rep. 2016 Sep 15;10(1):254
pubmed: 27634631
Yale J Biol Med. 2020 Mar 27;93(1):35-40
pubmed: 32226333
Leuk Res Rep. 2014 Jan 10;3(1):21-3
pubmed: 24596677
Ann Dermatol Venereol. 2019 Apr;146(4):292-296
pubmed: 30904278
World J Surg Oncol. 2010 Jun 28;8:53
pubmed: 20584320
Br J Haematol. 2004 Oct;127(2):173-83
pubmed: 15461623
Pathology. 2020 Jan;52(1):53-67
pubmed: 31735345
Breast. 2005 Feb;14(1):75-8
pubmed: 15695087
Biomed Res Int. 2018 Apr 3;2018:9413015
pubmed: 29850589
Haematologica. 2007 Apr;92(4):486-92
pubmed: 17488659
Lancet Oncol. 2009 Sep;10(9):895-902
pubmed: 19717091
Blood. 2018 Oct 11;132(15):1561-1567
pubmed: 30111607
Hautarzt. 1959 Aug;10:359-63
pubmed: 14432547
Appl Immunohistochem Mol Morphol. 2019 Oct;27(9):e91-e92
pubmed: 28582274
Pathol Int. 2019 Mar;69(3):148-154
pubmed: 30688388
World J Surg Oncol. 2014 Apr 08;12:88
pubmed: 24708809

Auteurs

Nitya Prabhakaran (N)

Department of Pathology, Surgical Pathology, Northwell Health, Greenvale, NY, USA.

Hassan Sheikh (H)

Department of Pathology, Long Island Jewish Medical Center, New Hyde Park, NY, USA.

Xinmin Zhang (X)

Department of Pathology, Northwell Health, Greenvale, NY, USA.

Silvat Sheikh-Fayyaz (S)

Department of Pathology, Northwell Health, Greenvale, NY, USA.

Classifications MeSH